Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Puma Biotechnology Inc (NYSE:PBYI)

68.08
Delayed Data
As of Sep 23
 +2.10 / +3.18%
Today’s Change
19.74
Today|||52-Week Range
95.18
-13.16%
Year-to-Date
Puma Biotechnology Shares Leap Forward
Sep 22 / TheStreet.com - Paid Partner Content
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy
Sep 20 / MotleyFool.com - Paid Partner Content
Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
Why Puma Biotechnology Inc Roared Higher Today
Sep 20 / MotleyFool.com - Paid Partner Content
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Sep 21 / MotleyFool.com - Paid Partner Content
Why Puma Biotechnology (PBYI) Stock Is Surging Today
Sep 20 / TheStreet.com - Paid Partner Content
Puma Biotechnology (PBYI) Shares March Higher, Can It Continue?
Sep 21 / Zacks.com - Paid Partner Content
Puma Biotechnology (PBYI): Moving Average Crossover Alert
Sep 13 / Zacks.com - Paid Partner Content